Acute Kidney Injury & Renal Drug Clearance

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Acute Kidney Injury & Renal Drug Clearance

Key Takeaways Explain This Topic AI

KDIGO AKI criteria include a creatinine rise of at least 0.3 mg/dL within 48 hours, at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/h for six hours.

Creatinine-based filtration estimates are less reliable during rapidly changing kidney function.

Renal accumulation of cefepime, baclofen, and active sedative or opioid metabolites can mimic new structural brain injury.

Volume responsiveness does not prove that a fluid bolus is beneficial when pulmonary or cerebral congestion is present.

Last updated: October 2026

Interpret Kidney Function in the Neurologic Context

Acute kidney injury (AKI) reduces clearance of water, electrolytes, endogenous solutes, and medications. Its neurologic consequences include encephalopathy, seizures, impaired drug elimination, and difficulty maintaining a prescribed sodium concentration. An unconscious patient cannot report urinary retention, flank pain, thirst, or medication adverse effects, so trends and objective examination are essential.

KDIGO defines AKI by a serum creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline known or presumed within seven days, or urine output below 0.5 mL/kg/h for six hours. Creatinine rises after filtration changes and depends on muscle mass and dilution. A near-normal value does not exclude early AKI, while an elevated value may reflect chronic disease. Compare baseline records, serial measurements, urine output, fluid balance, and the clinical timeline.

Localize the Renal Problem

Mechanism Examples Useful assessment

Reduced perfusion Hemorrhage, distributive shock, low cardiac output Perfusion, ultrasound, hemodynamic response, bleeding or infection source

Intrinsic injury Ischemic or nephrotoxic tubular injury, glomerular disease, interstitial nephritis Urine sediment, exposures, systemic signs, targeted studies

Obstruction Retention, catheter malfunction, ureteric obstruction Bladder assessment, catheter inspection, renal imaging when indicated

Urine sodium and fractional sodium excretion are context-dependent. Diuretics, chronic kidney disease, sepsis, and early tubular injury can complicate interpretation. A low fractional sodium excretion is not proof that more fluid will improve the patient. Urine microscopy may reveal granular casts in tubular injury, but absent casts do not exclude it. Proteinuria, dysmorphic erythrocytes, or cellular casts can direct a different evaluation.

Check simple reversible causes promptly. A blocked urinary catheter can create apparent oliguria; severe retention can cause both AKI and agitation. Do not assume that low urine output after osmotherapy is harmless. Conversely, a large urine volume can coexist with renal dysfunction because solute clearance and water excretion are different functions.

Preserve Perfusion Without Producing Congestion

Treat hemorrhage, infection, cardiac dysfunction, or obstruction. Use hemodynamic information to decide whether a fluid challenge is appropriate; a vasopressor or inotrope may be needed when vascular tone or cardiac function is the limiting problem. Monitor lungs, oxygenation, sodium, and cerebral perfusion during resuscitation. A favorable increase in stroke volume with preload does not guarantee that the benefit outweighs the harm of additional edema.

Review nephrotoxins and contrast exposure, but do not automatically defer a time-sensitive CTA for suspected large-vessel occlusion or another life-threatening vascular diagnosis. Balance the diagnostic benefit and kidney risk with the responsible teams. Avoid unsupported promises that a particular prophylactic drug prevents contrast-associated AKI in all patients.

Loop diuretics can manage fluid overload but do not reverse established renal tissue injury. An increase in urine output after furosemide does not demonstrate recovered filtration. Track the total clinical response rather than using urine volume alone as proof that dialysis is unnecessary.

Drug Clearance and Apparent Neurologic Deterioration

Renal dysfunction can prolong sedation and cause neurotoxicity. Cefepime accumulation may produce encephalopathy, myoclonus, and EEG abnormalities. Baclofen toxicity can cause profound coma. Levetiracetam requires maintenance-dose adjustment; loading decisions in emergencies are a separate question. Midazolam's active metabolites, morphine metabolites, and hydromorphone's neuroexcitatory metabolite can accumulate. Fosphenytoin or phenytoin assessment becomes more difficult because uremia and low albumin alter protein binding; a total level may be misleading, and a measured free level is preferable when available.

Medication dosing during AKI is not a one-time admission calculation. Filtration can worsen or recover rapidly, and continuous renal replacement can remove some drugs substantially. Coordinate with pharmacy regarding loading, maintenance, therapeutic monitoring, and the exact dialysis modality. Also consider augmented renal clearance in selected younger trauma patients, where underexposure to renally eliminated antibiotics or antiseizure drugs can occur despite a normal creatinine.

Uremia Versus Other Causes of Coma

Uremic encephalopathy may include inattention, asterixis, myoclonus, seizures, and diffuse EEG slowing. There is no single BUN threshold that establishes the diagnosis or excludes another emergency. Investigate hypoglycemia, sodium disorders, infection, structural lesions, and medication accumulation. Renal replacement is considered for clinically important uremic complications and other urgent indications, not solely because a fixed creatinine number has been crossed.

A useful vignette is a patient with a stable head CT whose kidney function deteriorates after shock while receiving renally cleared medications. The correct approach includes stopping or adjusting the suspected offending drug, assessing EEG when indicated, and treating renal and systemic problems. Increasing sedation because myoclonus is assumed to be agitation may worsen diagnostic uncertainty.

Source checked October 17, 2026: KDIGO AKI guideline . This published guideline is distinct from proposed updates or consultation drafts.